These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4414661)

  • 1. Methotrexate treatment for advanced bladder cancer.
    Hall RR; Bloom HJ; Freeman JE; Nawrocki A; Wallace DM
    Br J Urol; 1974 Aug; 46(4):431-8. PubMed ID: 4414661
    [No Abstract]   [Full Text] [Related]  

  • 2. Cisplatin as adjunctive treatment for invasive bladder carcinoma: tolerance and toxicities.
    Einstein AB; Shipley W; Coombs J; Cummings KB; Soloway MS; Hawkins I
    Urology; 1984 Apr; 23(4 Suppl):110-7. PubMed ID: 6538712
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral VP-16-213 in transitional cell carcinoma of the bladder: a phase II study.
    Panduro J; Hansen M; Hansen HH
    Cancer Treat Rep; 1981; 65(7-8):703-4. PubMed ID: 7248987
    [No Abstract]   [Full Text] [Related]  

  • 4. Methotrexate given concurrently with radiotherapy in the treatment of transitional cell carcinoma.
    Tomlinson MJ; Lancaster JF; Bullimore JA; Smith PJ
    Br J Radiol; 1988 Oct; 61(730):959-60. PubMed ID: 3191325
    [No Abstract]   [Full Text] [Related]  

  • 5. Methotrexate for superficial bladder cancer.
    Hall RR
    Prog Clin Biol Res; 1985; 185B():143-9. PubMed ID: 3898139
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasma methotrexate concentrations in urothelial cancer chemotherapy].
    Kitamura Y; Watanabe M; Komatsubara S; Sakata Y
    Hinyokika Kiyo; 1990 Sep; 36(9):991-6. PubMed ID: 2239621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate in the treatment of metastatic and recurrent primary transitional cell carcinoma.
    Oliver RT; England HR; Risdon RA; Blandy JP
    J Urol; 1984 Mar; 131(3):483-5. PubMed ID: 6230463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further clinical studies of trimethylpurin-6-ylammonium chloride (NSC-51095) in malignant disease with special emphasis on cancer of urinary bladder.
    Phillips RW
    Cancer Chemother Rep; 1970 Jun; 54(3):181-5. PubMed ID: 4947750
    [No Abstract]   [Full Text] [Related]  

  • 9. The Nb rat transitional cell bladder carcinoma model: dose response to methotrexate and adriamycin.
    Drago JR; Nesbitt JA
    Anticancer Res; 1986; 6(5):1019-20. PubMed ID: 3800312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers].
    Takenaka A; Gotoh A; Hara I; Gohji K; Ogawa T; Arakawa S; Matsumoto O; Kamidono S; Hamami G; Itani A
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1909-15. PubMed ID: 2393308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy with methotrexate and cisplatin prior to radiotherapy for invasive transitional cell carcinoma of the bladder. Assessment of feasibility and toxicity.
    Howard GC; Cornbleet MA; Whillis D; Hargreave TB; Chisholm GD
    Br J Urol; 1991 Nov; 68(5):490-4. PubMed ID: 1747724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined surgery and adjuvant chemotherapy with high dose methotrexate and folinic acid rescue (HDMTX-CF) for infiltrating tumours of the bladder.
    Socquet Y
    Br J Urol; 1981 Oct; 53(5):439-43. PubMed ID: 6974578
    [No Abstract]   [Full Text] [Related]  

  • 13. [MEC treatment (methotrexate, etoposide, cisplatin) for urothelial cancer].
    Miura T; Murai T; Shimura H; Kondo I
    Gan To Kagaku Ryoho; 1992 May; 19(5):731-3. PubMed ID: 1580650
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic oral methotrexate therapy for multiple superficial bladder carcinoma.
    Hall RR; Herring DW; Gibb I; Heath AB
    Br J Urol; 1981 Dec; 53(6):582-4. PubMed ID: 7317746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU Group protocol 30867.
    Fosså SD; Splinter T; Roozendaal KJ; Veenhof KH; Pavone-Macaluso M; Calciati A; de Pauw M; Sylvester R
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):389-90. PubMed ID: 2702991
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiation therapy and cystectomy.
    Prout GR
    Urology; 1984 Apr; 23(4 Suppl):104-9. PubMed ID: 6710724
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adjuvant chemotherapy following total cystectomy for invasive bladder cancer with bleomycin, vincristine and methotrexate].
    Takeuchi S; Yamada T; Sekine H; Katoh M; Washizuka M; Fukui I; Yokokawa M
    Hinyokika Kiyo; 1984 Nov; 30(11):1619-25. PubMed ID: 6084949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma--response rate and pitfalls. MRC Subgroup in Advanced Bladder Cancer (on behalf of the MRC Urological Working Party).
    Fosså SD; Harland SJ; Kaye SB; Raghavan D; Russell JM; Parmar MK; Uscinska BM; Wood R
    Br J Urol; 1992 Aug; 70(2):161-8. PubMed ID: 1393439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors.
    Higby DJ; Wallace HJ; Albert DJ; Holland JF
    Cancer; 1974 May; 33(5):1219-5. PubMed ID: 4856724
    [No Abstract]   [Full Text] [Related]  

  • 20. Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial.
    Boccardo F; Pace M; Guarneri D; Canobbio L; Curotto A; Martorana G
    Cancer; 1994 Apr; 73(7):1932-6. PubMed ID: 8137220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.